PHILADELPHIA, Nov. 20, 2008 (GLOBE NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, today announced the appointment of Ruth Thieroff-Ekerdt, M.D., to the newly created position of Chief Medical Officer of Eurand Pharmaceuticals, Inc., effective December 1, 2008. She will be based in the Company's Yardley, Pa., office.
